Type I Error and Power in Noninferiority/Equivalence Trials with Correlated Multiple Endpoints: An Example from Vaccine Development Trials
Authors:
- 31 December 2004
- journal article
- Published by Taylor & Francis in Journal of Biopharmaceutical Statistics
- Vol. 14 (4) , 893-907
Abstract
Clinical trials necessary for the development of new treatment often require testing of multiple endpoints for equivalence or noninferiority relative to an existing effective standard therapy. An example is a vaccine study with multiple antibody measurements in sera of subjects receiving a combination vaccine such as a pneumococcal vaccine, which contains many different serotypes of the pneumococcal organism. This article describes testing methods for the demonstration of simultaneous marginal equivalence or noninferiority of two treatments on each component of the response vector that follows a multivariate normal distribution. Systematic simulation studies are conducted to evaluate the performance of the testing method and to examine under what conditions the power is substantially different if the multiple endpoints are assumed to be independent when they are actually strongly correlated. Data from an illustrative example are used to describe how the study power can be evaluated in the design of the trials.Keywords
This publication has 7 references indexed in Scilit:
- Assessment of equivalence on multiple endpointsStatistics in Medicine, 2001
- ON TESTING EQUIVALENCE OF THREE POPULATIONSJournal of Biopharmaceutical Statistics, 1999
- Design Issues in Noninferiority/Equivalence TrialsDrug Information Journal, 1999
- Bioequivalence trials, intersection-union tests and equivalence confidence setsStatistical Science, 1996
- Testing Hypotheses about an Identified Treatment when there are Multiple EndpointsJournal of the American Statistical Association, 1992
- Some general results on least favorable parameter configurations with special reference to equivalence testing and the range statisticJournal of Statistical Planning and Inference, 1991
- “Proving the null hypothesis” in clinical trialsControlled Clinical Trials, 1982